{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3","upperLimit":"4","value":"3.5"},{"groupId":"OG001","lowerLimit":"2","upperLimit":"10","value":"5.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"description":"The measuer is reported as time course (i.e., how many month) to see papilloma recurrence if there is any such recurrence.","dispersionType":"Full Range","groups":[{"description":"treated with once-time routine surgery","id":"OG000","title":"Control"},{"description":"treated with both of once-time PDL and 9-month Celebrex","id":"OG001","title":"Experiment"}],"paramType":"MEAN","populationDescription":"12-month follow-up","reportingStatus":"POSTED","timeFrame":"12 months","title":"Time Course (Month) With Papilloma Recurrence During 12-month Follow up","type":"SECONDARY","unitOfMeasure":"month"}